<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03496350</url>
  </required_header>
  <id_info>
    <org_study_id>SAHA</org_study_id>
    <nct_id>NCT03496350</nct_id>
  </id_info>
  <brief_title>Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression</brief_title>
  <official_title>Culturally Adapted Transdiagnostic Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Linkoeping University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Linkoeping University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of a culturally adapted
      internet-administrated cognitive behaviour therapy (ICBT) in Arabic for anxiety and
      depression
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will compare the effect of the intervention against a wait-list control. The
      intervention tested is based on cognitive behavior therapy delivered over the internet via a
      secure treatment platform. Participants in the study are recruited from the general public
      via social media. The intervention is in Arabic.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants get randomly assigned to either treatment or wait-list control.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Patient Health Questionnaire (PHQ-9)</measure>
    <time_frame>pre-treatment ,week 3, week 6, week 8 and 12 months post-treatment</time_frame>
    <description>The PHQ-9 is a nine-item self-report questionnaire that measures symptoms of depression. It is scored from 0-27 with a higher score reflecting more severe symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Generalised Anxiety Disorder-7-item scale, (GAD-7)</measure>
    <time_frame>pre-treatment ,week 3, week 6, week 8 and 12 months post-treatment</time_frame>
    <description>The GAD-7 is a seven-item self-report questionnaire that measures symptoms of anxiety. It is scored from 0-21 with a higher score reflecting more severe symptoms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alcohol Use Disorder Identification Test (AUDIT)</measure>
    <time_frame>pre-treatment, week 8</time_frame>
    <description>Measures alcohol consumption, drinking behaviors, and alcohol-related problems. It is scored from 0-40 with higher scores reflecting more alcohol consumption, drinking behaviors, and alcohol-related problems.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insomnia Severity Index (ISI)</measure>
    <time_frame>pre-treatment, week 8</time_frame>
    <description>Self-reported symptoms of insomnia. It is scored from 0-28 with higher scores reflecting more symptoms of insomnia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of Events Scale - Revised (IES-R)</measure>
    <time_frame>pre-treatment, week 8</time_frame>
    <description>Self-reported symptoms of post-traumatic stress. It is scored from 0-88 where higher scores reflect more symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived Stress Scale (PSS)</measure>
    <time_frame>pre-treatment, week 8</time_frame>
    <description>Self-reported stress-related symptoms. It is scored from 0-56 with higher scores reflecting more symtoms of perceived stress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>&quot;Brunnsviken Brief Quality of Life Scale&quot; (BBQ)</measure>
    <time_frame>pre-treatment, week 8</time_frame>
    <description>Self-reported quality of life. The scale is scored from 0-96 with a higher score reflecting higher self-reported quality of life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anxiety</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Internet CBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Internet-based cognitive behavioural therapy in Arabic with therapeutic guidance through email.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait-list</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Wait-list control</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet-delivered CBT</intervention_name>
    <description>Culturally adapted transdiagnostic internet-delivered CBT in Arabic</description>
    <arm_group_label>Internet CBT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be above 18 years of age

          -  Have symptoms of anxiety and/or depression

          -  Be able to read and write in Arabic

          -  Have access to computer or smartphone

        Exclusion Criteria:

          -  Suicidal ideation

          -  Alcohol addiction

          -  Other major primary psychiatric disorder

          -  Ongoing psychological treatment

          -  Recent (during last 4 weeks) change in psychiatric medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Andersson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Linkoeping University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerhard Andersson, PhD</last_name>
    <email>gerhard.andersson@liu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tomas Nygren, MsC</last_name>
    <phone>0046760733837</phone>
    <email>tomas.nygren@liu.se</email>
  </overall_contact_backup>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2018</study_first_submitted>
  <study_first_submitted_qc>April 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2018</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Linkoeping University</investigator_affiliation>
    <investigator_full_name>Gerhard Andersson</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

